Details for New Drug Application (NDA): 040590
✉ Email this page to a colleague
NDA 040590 describes ERGOTAMINE TARTRATE AND CAFFEINE, which is a drug marketed by Hikma Intl Pharms and Mikart and is included in two NDAs. It is available from one supplier. Additional details are available on the ERGOTAMINE TARTRATE AND CAFFEINE profile page.
The generic ingredient in ERGOTAMINE TARTRATE AND CAFFEINE is caffeine; ergotamine tartrate. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the caffeine; ergotamine tartrate profile page.
The generic ingredient in ERGOTAMINE TARTRATE AND CAFFEINE is caffeine; ergotamine tartrate. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the caffeine; ergotamine tartrate profile page.
Summary for 040590
| Tradename: | ERGOTAMINE TARTRATE AND CAFFEINE |
| Applicant: | Mikart |
| Ingredient: | caffeine; ergotamine tartrate |
| Patents: | 0 |
Pharmacology for NDA: 040590
| Physiological Effect | Central Nervous System Stimulation |
Suppliers and Packaging for NDA: 040590
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ERGOTAMINE TARTRATE AND CAFFEINE | caffeine; ergotamine tartrate | TABLET;ORAL | 040590 | ANDA | Cintex Services, LLC | 24470-917 | 24470-917-10 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (24470-917-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG;1MG | ||||
| Approval Date: | Sep 16, 2005 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
